Legionella Testing Kits Market By Type (Culture Media, Urine Antigen Testing, Polymerase Chain Reaction, Serology, Direct Fluorescent Antibody Test) , By End User (Hospitals and Clinics, Clinical Laboratories, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Legionella Testing Kits Market
The legionella testing kits market was valued at $324.0 million in 2023 and is projected to reach $684.5 million by 2033, growing at a CAGR of 7.7% from 2024 to 2033.
A legionella testing kit is a rapid do-it-yourself tester which enables detection of the bacteria Legionella. This kit is essentially used in spaces such as care homes & hospitals, hospitality, pools & fountains, and cooling towers. The testing is performed using diverse biomolecular processes such as culture method, polymerase chain reaction technique, or immunological assay. The key attributes of the kit include short turnaround time, high precision, and ease of usage.
Increase in awareness about the prevention of water borne diseases is a key driver of the legionella testing kits market. Commercial and public buildings have strengthened their regulations regarding public safety, boosting the adoption of testing kits. In addition, advancements in technology have enhanced the efficacy and reliability of the kits, thereby augmenting the development of the market. In recent times, quick delivery of results and integration of the kits with digital solutions are the prominent trends acquiring traction. To facilitate seamless analysis and reporting of test results, manufacturers are designing kits with the ability to be assimilated with digital data management systems. This integration assists in tracking the patterns of water quality & safety and making effective decisions.
However, the cost of advanced version of kits with high precision and accuracy remains significantly high, restricting small organizations from purchasing them. Furthermore, the collection and handling of the sample & kit is a complex process which requires training & practice. Slight contamination of the kit impacts its reliability, thereby hampering the growth of the market. Contrarily, efforts by governments to conduct periodic water testing in public places and buildings are presenting lucrative opportunities for the market. For instance, the U.S. General Service Administration conducted water testing across several federal buildings in January 2024 to ensure the wellness of individuals visiting and working in the buildings.
Segment ReviewThe legionella testing kits market is segmented into type, end user, and region. On the basis of type, the market is divided into culture media, urine antigen testing, polymerase chain reaction, serology, and direct fluorescent antibody test. Depending on end user, it is classified into hospitals & clinics, clinical laboratories, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key FindingsOn the basis of type, the polymerase chain reaction segment accounted for the largest share in 2023.
Depending on end user, the hospitals & clinics segment acquired a high stake in the market in 2023.
Region wise, North America was the highest revenue generator in 2023.
Competition AnalysisThe leading players operating in the global legionella testing kits market include IDEXX Laboratories, Inc., Thermo Fisher Scientific, Merck Group KGaA, Pall Corporation, Bio-Rad Laboratories, Inc., Abbott Laboratories, Hygiena, Veolia Water Technologies, Pro-Lab Diagnostics, and phigenics, llc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.
Key Market SegmentsBy TypeCulture Media
Urine Antigen Testing
Polymerase Chain Reaction
Serology
Direct Fluorescent Antibody Test
By End UserHospitals and Clinics
Clinical Laboratories
Others
By RegionNorth America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
Key Market Players
IDEXX Laboratories, Inc.
Thermo Fisher Scientific Inc.
Merck Group KGaA
Pall Corporation
Bio-Rad Laboratories, Inc.
Abbott Laboratories
Hygiena
Veolia Water Technologies
Pro-Lab Diagnostics
Phigenics, LLC